Send mail to Author

Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial) (Article)

Please indicate your contact information and select, which author you want to contact.



 
 _    _     _____     _____    __   __    _____     ______  
| |  | ||  |  ___||  |__  //   \ \\/ //  /  ___||  /_   _// 
| |/\| ||  | ||__      / //     \ ` //  | // __     -| ||-  
|  /\  ||  | ||__     / //__     | ||   | \\_\ ||   _| ||_  
|_// \_||  |_____||  /_____||    |_||    \____//   /_____// 
`-`   `-`  `-----`   `-----`     `-`'     `---`    `-----`  
                                                            
 


Back to frontdoor view